PTGX
USDProtagonist Therapeutics Inc. Common Stock
$76.500+1.060 (1.405%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$75.440
High
$78.010
Low
$75.440
Volume
0.17M
Company Fundamentals
Market Cap
4.8B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.13M
Exchange
NGM
Currency
USD
52-Week Range
Low $33.31Current $76.500High $93.25
Related News
AccessWire
Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting
NEWARK, CALIFORNIA / ACCESS Newswire / November 3, 2025 / Protagonist Therapeutics, Inc. announced that clinical data on rusfertide in polycythemia vera, including the
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.